COMPANY PROFILE · UPDATED 18 NOV 2025

Verge Genomics

Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate development of life-saving treatments for neurodegenerative diseases.

vergegenomics.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2015
Headcount: 74
Open roles: 0
Last raised: Series B · Sign in to view

LEADERSHIP

Founders & key people

OPEN ROLES

Roles at Verge Genomics

Employbl doesn’t track Verge Genomics’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →

FUNDING

Capital raised

Total raised

$134,120,000

Investors

Y Combinator Slow VenturesALS Investment FundAgent CapitalAlumni Ventures GroupBasis Set VenturesBlackRockCastor VenturesDraper AssociatesEli Lilly and CompanyFitz Gate VenturesGreat Oaks ManagementIA VenturesJonathan DowneyKarlin VenturesKimberly VogelLifeforce CapitalMerckOS FundRefactor CapitalS32Tao Capital PartnersThresholdTwo Sigma VenturesVulcan CapitalWuXi AppTec Co.

Funding rounds

Series B
BlackRock, Merck, S32, ALS Investment Fund, Threshold, Vulcan Capital, Tao Capital Partners, Lifeforce Capital, Eli Lilly and Company, Alumni Ventures Group
$98MDec 15, 2021
Series A
Threshold, Agent Capital, ALS Investment Fund, OS Fund, WuXi AppTec Co., Great Oaks Management, Basis Set Ventures, Lifeforce Capital, Jonathan Downey, Castor Ventures, Fitz Gate Ventures, Tao Capital Partners, Alumni Ventures Group
$32MJul 16, 2018
Seed
IA Ventures, Two Sigma Ventures, Draper Associates, Great Oaks Management, Slow Ventures, Karlin Ventures, Refactor Capital, OS Fund, Kimberly Vogel, Lifeforce Capital
$4MOct 28, 2015
Pre Seed
Y Combinator
$120KJun 17, 2015